Changes in virological and immunological parameters from one patient with viral rebound on study.
- Julian H. Elliott (281412)
- Fiona Wightman (659651)
- Ajantha Solomon (654590)
- Khader Ghneim (170017)
- Jeffrey Ahlers (659652)
- Mark J. Cameron (132906)
- Miranda Z. Smith (90618)
- Tim Spelman (143159)
- James McMahon (659653)
- Pushparaj Velayudham (659654)
- Gregor Brown (659655)
- Janine Roney (659656)
- Jo Watson (524591)
- Miles H. Prince (659657)
- Jennifer F. Hoy (157656)
- Nicolas Chomont (175516)
- Rémi Fromentin (659658)
- Francesco A. Procopio (493850)
- Joumana Zeidan (659659)
- Sarah Palmer (69273)
- Lina Odevall (659660)
- Ricky W. Johnstone (249820)
- Ben P. Martin (659661)
- Elizabeth Sinclair (10445)
- Steven G. Deeks (131630)
- Daria J. Hazuda (263416)
- Paul U. Cameron (210950)
- Rafick-Pierre Sékaly (118474)
- Sharon R. Lewin (130160)
Publication date
November 2014
DOIAbstract
<p>Changes in (A) CA-US HIV RNA (red), (B) plasma HIV RNA (green) and (C) CA-HIV DNA (blue) are shown as the mean± SD for replicates of CA-US HIV RNA and HIV DNA. Programmed death-1 (PD1) expression on CD4+ and CD8+ CD45RA- T-cells is shown. Grey shaded box represents the time on vorinostat. (D) Dot plot analysis of flow cytometry for co-expression of PD-1 and CD45RA on CD4+ (top panel) and CD8+ (lower panel) T-cells at baseline, after 7 days of vorinostat and at day 84 of follow up.</p
Add to ORKG